Target intelligence / Profile preview

Mitochondrial cytochrome bc₁ complex (Cytochrome bc₁ complex)

Target
Cytochrome bc₁ complex
Molecular classification
Enzyme, Electron transport complex (Complex III of mitochondrial respiratory chain), Integral membrane protein
01

Overview

The mitochondrial cytochrome bc₁ complex (complex III) is an intrinsic membrane protein dimer consisting of several subunits, most notably cytochrome b, cytochrome c₁, and the Rieske iron-sulfur protein. It catalyzes the oxidation of ubiquinol and the reduction of cytochrome c via the Q-cycle mechanism, generating a proton gradient essential for mitochondrial ATP production. Dysfunction in this complex can result in mitochondrial myopathies and contributes to increased production of reactive oxygen species, which are implicated in aging and various diseases. The complex is a key therapeutic target, with several drugs and research inhibitors acting by binding its quinone sites and disrupting electron transfer. Structural studies reveal it functions as a dimer, with coordinated binding and electron transfer across subunits.

Other names
Electron transport complex IIIComplex IIIUbiquinol-cytochrome c reductaseCytochrome b-c₁ complexRespiratory chain complex III
02

Mechanism of action

Inhibition of electron transport by blocking quinone (ubiquinol) binding sites (Qo/Qi sites) or interfering with electron transfer; Disruption of the proton gradient, leading to impaired ATP synthesis

03

Biological functions

Electron transport in mitochondrial respirationGeneration of proton gradient for ATP synthesisRedox reactions (oxidation-reduction)Energy metabolism
04

Disease associations

Mitochondrial myopathiesNeurodegenerative disease (age-related damage)Other mitochondrial dysfunctions
05

Safety considerations

Off-target inhibition leads to cellular energy deficiency and may exacerbate oxidative damageCardiac and muscular side effects due to impact on ATP synthesis
06

Interacting drugs

Stigmatellin

4 more in the full profile.

07

Biomarkers

Mutations in cytochrome b and other bc₁ complex subunits (associated with myopathies)Increased mitochondrial superoxide (linked to complex dysfunction)

Beyond the preview

Go deeper on Mitochondrial cytochrome bc₁ complex (Cytochrome bc₁ complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial cytochrome bc₁ complex (Cytochrome bc₁ complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call